A decontamination strategy for resolving SARS-CoV-2 amplicon contamination in a next-generation sequencing laboratory.

"Declarations Conflict of interestThe authors have no competing interests to declare that are relevant to the content of this article. Ethical approvalThis study was approved under ethics number HSD2020/1860/2710 by the Health Sciences Research Ethics Committee of the University of Free State, Bloemfontein, South Africa. Conflict of interest The authors have no competing interests to declare that are relevant to the content of this article."

"Funding This work was supported by the Bill and Melinda Gates Foundation (African Enteric Viruses Genome Initiative grant number BMGF OPP1180423_2017). Other funding grants awarded to M.M.N. that funded this research include: South Africa Medical Research Council (self-initiated research grant), WHO, grant number 2017/757922-0; the National Research Foundation (competitive programme for rated researchers, grant number 120814) and Poliomyelitis Research Foundation (grant number 19/16 and grant number 21/77). The views and opinions expressed in this article are not necessarily those of the funding and affiliated institutions but solely those of the authors of this publication."